Clinical Trials Sign up for updates News Capella Contact Us
  • GLOBAL
 

Social Media Community Guidelines

We recognize the important role that social media plays in the lives of the people and communities we seek to serve. Having a presence on social media channels provides us an unique opportunity to inform, educate and engage with patients, families, healthcare professionals, researchers, potential employees, investors and anyone else who’s interested in what we’re doing, and we are committed to interacting with all stakeholders legally, ethically and in accordance with regulatory standards.

 

We invite you to follow us and engage with our content, however please note that by replying to or commenting on our social media posts or by following our social media channels, you are agreeing to abide by and are subject to the following Social Media Community Guidelines, which apply in addition to the Terms and Conditions or other legal notices specific to each social channel.

  1. There are certain topics we are not able or willing to discuss on social media. Specifically, we will not:
    1. Offer medical advice, whether related to our approved or investigational products, our disease states of interest, or our genetic testing or counseling programs. An individual’s healthcare provider is the best resource for questions about their health.
      1. Please note that from time to time, we may share information about medical or health topics; this should not be construed as medical advice but rather as educational content;
        1. The educational information provided on social media related to medical or health topics is always based on true, accurate and reliable scientific data
      2. Respond to adverse event reports and/or product complaints, and any such replies or comments will be deleted, as social media is not the appropriate forum for these kinds of reports. If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861
        1. Replies or comments that contain adverse events or product complaints about any Alnylam product will be recorded prior to deletion and reported to health authorities as required by law and regulations.
      3. Discuss or respond to comments about:
        1. Alnylam financial performance, partnerships, litigation or business operations;
        2. Alnylam people or personnel changes, including members of Alnylam’s Board of Directors or Scientific Advisory Board;
        3. Alnylam processes or procedures.
  1. The following types of replies and comments are not acceptable and we reserve the right to hide or delete those that:
    1. Use profane, defamatory, libelous, offensive, hateful or demeaning language, video, images or other media;
    2. Are disparaging or threatening, to Alnylam, other companies or individuals
    3. Are misleading, fraudulent or deceptive;
    4. Provide medical advice of any kind, including through links to third party content or websites;
    5. Are related to any of Alnylam’s approved or investigational products (including adverse events and product complaints);
    6. Contain proprietary, confidential, sensitive or non-public information about, or related to, Alnylam, other companies or individuals;
    7. Contain personal and/or identifying information about individuals (including the person who replies or comments);
    8. Are promotional, solicitous or constitute advertising for other products or services;
    9. Are excessively repetitive, SPAM-like in nature or otherwise disruptive to the community;
    10. Contain links, images, videos, or other media not owned by Alnylam.
  1. We reserve the right to block any social media user/account that violates these Community Guidelines.
  1. We reserve the right to engage or not engage with replies or comments on a case-by-case basis and make no commitments related to response time. We may contact social media users via private message if we have the ability to do so.
  1. We may occasionally share links to third-party sites when we feel that the information is relevant or helpful, however, please note that this does not in any way constitute an official endorsement of the author, website, company who owns the website or all of the information on that website. We are not responsible for the terms and conditions, privacy policy or content of any website accessed through links or references in our social properties.
  1. In addition to the privacy policy and terms of use of the third-party social media platform, your use of our social media channels are governed by Alnylam’s Terms of Use and Privacy Policy which can be viewed here.
  1. While we monitor our social media channels and reserve the right to delete replies or comments, or screen any comments before posting, Alnylam is not responsible for content posted by third parties.
  1. Social media accounts that Alnylam follows or that follow Alnylam do not indicate an endorsement of the account owner or their products and/or services.
  1. Alnylam reserves the right to update these Social Media Community Guidelines at any time in its sole discretion.

If you have any questions regarding our Social Media Community Guidelines, please contact socialmedia@alnylam.com.

SIGN UP FOR EMAIL UPDATES

Receive news and updates on the work at Alnylam that affects you most.